Skip to main content
SpringerLink
Log in

Interindividual variations in cytokine levels following cardiopulmonary bypass

  • Originals
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Summary

Cardiopulmonary bypass (CPB) is associated with an inflammatory response, mainly caused by the trauma of surgery, contact of blood with the artificial surface of the circuit, and reperfusion injury, resulting in increased capillary permeability, respiratory distress, low cardiac output, and multiorgan failure. The inflammatory reaction includes an activation of the humoral and cellular immune system with enhanced release of cytokines. The present study focused on the effect of CPB on the time course of pro- and anti-inflammatory cytokines. In 20 patients undergoing coronary artery bypass grafting, the plasma concentration of interferon (IFN)-γ, tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, and IL-10 was investigated pre-, intra-, and postoperatively by enzyme-linked immunosorbent assay technique. With the exception of IFN-γ, all the other cytokines could be detected in the patients plasma. However, neither TNF-α nor IL-1β and IL-2 revealed significant changes in concentration during the investigated time period. In contrast, IL-6 and IL-8 levels peaked early postoperatively, reaching median concentrations of 430 pg/ml (221 pg per ml/558 pg per ml; lower/upper quartiles, respectively) and approximately 12 pg/ml (0/17 pg/ml; lower/upper quartiles, respectively). IL-4 and IL-10, respectively, revealed maximal concentrations of approximately 2 pg/ml (0/39 pg/ml; lower/upper quartiles, respectively) and 208 pg/ml (76 pg per ml/380 pg per ml; lower/upper quartiles, respectively) immediately after protamine administration, preceding the maximal concentration of IL-6. The degree of the observed modulation of cytokine patterns during and after CPB seemed to be patient-dependent, since large interindividual variations in cytokine levels were observed, not only preoperatively, but especially during and following CPB. However, IL-6 and IL-10 showed the least interindividual variations, suggesting that these cytokines may give reliable information regarding modulation of the immune response following CPB and its consequences for the patient’s outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD (1983) Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 86:845–857

    PubMed  CAS  Google Scholar 

  2. Bonser RS, Dave J, Gademsetty M, Carter P, Davies E, Taylor P, Gaya H, Lennox SC, Vergani D (1990) Complement activation before, during and after cardiopulmonary bypass. Eur J Cardiothorac Surg 4:291–296

    Article  PubMed  CAS  Google Scholar 

  3. Babin-Ebell J, Neukam K, Steinbrückner BE, Steigerwald U, Keller F, Elert O (1995) Aktivierung von Gerinnung und Fibrinolyse während der extrakorporalen Zirkulation — Einfluß von Rollerpumpe, Zentrifugalpumpe und heparinbeschichteten Oberflächen. Z Herz-, Thorax-, Gefäßchir 9:196–204

    Google Scholar 

  4. Steinbrückner BE, Steigerwald U, Keller F, Neukam K, Elert O, Babin-Ebell J (1995) Centrifugal and roller pumps — are there differences in coagulation and fibrinolysis during and after cardiopulmonary bypass? Heart Vessels 10:46–53

    Article  Google Scholar 

  5. Grossmann R, Babin-Ebell J, Misoph M, Schwender S, Neukam K, Hickethier Th, Elert O, Keller F (1996) Changes in coagulation and fibrinolytic parameters caused by extracorporeal circulation. Heart Vessels 11:310–317

    Article  Google Scholar 

  6. Tanaka K, Morimoto T, Yada I, Kusagawa M, Deguchi K (1987) Physiologic role of enhanced fibrinolytic activity during cardiopulmonary bypass in open heart surgery. Trans Am Soc Artif Intern Organs 33:505–509

    CAS  Google Scholar 

  7. Schmid FX, Zhou X, Hake U, Mayer E, Habermehl P, Zepp F, Eberle B, Oelert H (1996) Zell-vermittelter Immunstatus während und nach Operationen mit und ohne extrakorporaler Zirkulation. Z Herz-, Thorax-, Gefäßchir 10:153–161

    Google Scholar 

  8. Steinberg JB, Kapelanski DP, Olson JD, Weiler JM (1993) Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 106:1008–1016

    PubMed  CAS  Google Scholar 

  9. Hashimoto K, Miyamoto H, Suzuki K, Horikoshi S, Matsui M, Arai T, Kurosawa H (1992) Evidence of organ damage after cardiopulmonary bypass. The role of elastase and vasoactive mediators. J Thorac Cardiovasc Surg 104(3):666–673

    PubMed  CAS  Google Scholar 

  10. Shenkin A, Fraser WD, Series J, Winstanley FP, McCartney AC, Burns HJ, Van-Damme J (1989) The serum interleukin 6 response to elective surgery. Lymphokine Res 8:123–127

    PubMed  CAS  Google Scholar 

  11. Gauldie J, Richards C, Harnish D, Lansdorp P, Baumann H (1987) Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci 84:7251–7255

    Article  PubMed  CAS  Google Scholar 

  12. Kawamura T, Wakusawa R, Kazutoshi O, Inada S (1993) Elevation of cytokines during open heart surgery with cardiopulmonary bypass: Participation of interleukin 8 and 6 in reperfusion injury. Can J Anaesth 40:1016–1021

    PubMed  CAS  Google Scholar 

  13. Casey LC (1993) Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg 56:92–96

    Article  Google Scholar 

  14. Frering B, Philip I, Dehoux M, Rolland C, Langlois JM, Desmonts JM (1994) Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg 108:636–641

    PubMed  CAS  Google Scholar 

  15. Kawahito K, Kawakami M, Fujiwara T, Murata S, Yamaguchi A, Mizuhara A, Adachi H, Ino T (1995) Proinflammatory cytokine levels in patients undergoing cardiopulmonary bypass. Does lung reperfusion influence the release of cytokines? ASAIO J 41:M775–778

    Article  PubMed  CAS  Google Scholar 

  16. Steinberg BM, Grossi EA, Schwartz DS, McLoughlin DE, Aguinaga M, Bizekis C, Greenwald J, Flisser A, Spencer FC, Galloway AC, Colvin SB (1995) Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass. Ann Thorac Surg 60:525–529

    Article  PubMed  CAS  Google Scholar 

  17. Misoph M, Babin-Ebell J, Schwender S, Grossmann R, Keller F, Elert O (1997) Response of the cellular immune system to cardiopulmonary bypass in vivo. Thorac Cardiovasc Surg 45

  18. Nijsten MW, de Groot ER, ten Duis HJ, Klasen HJ, Hack CE, Aarden LA (1987) Serum levels of interleukin 6 and acute phase responses. Lancet II (8564):921

  19. Stouthard JM, Levi M, Hack CE, Veenhof CHN, Romijn HA, Sauerwein HP, van der Poll T (1996) Interleukin-6 stimulates coagulation, not fibrindysis, in humans. Thromb Haemost 76:738–742

    Google Scholar 

  20. Borowiec JW, Hagman L, Tötterman TH, Pekna M, Venge P, Thelin S (1995) Circulating cytokines and granulocyte-derived enzymes during complex heart surgery. Scand J Thor Cardiovasc Surg 29:167–174

    CAS  Google Scholar 

  21. Cruickshank AM, Fraser WD, Burns HJ, Van-Damme J, Shenkin A (1990) Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci Cokh 79:161–165

    CAS  Google Scholar 

  22. Butler J, Chong GL, Baigrie RJ, Pillai R, Westaby S, Rocker GM (1992) Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation. Ann Thorac Surg 53:833–838

    Article  PubMed  CAS  Google Scholar 

  23. Wan S, DeSmet JM, Barvais L, Goldstein M, Vincent JL, LeClerk JL (1996) Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 112:806–811

    Google Scholar 

  24. Kukielka GL, Smith CW, Manning AM, Youker KA, Michael LH, Entman ML (1995) Induction of interleukin-6 synthesis in the myocardium. Circulation 92:1866–1875

    PubMed  CAS  Google Scholar 

  25. Dauber IM, Parsons PE, Welsh CH, Giclas PC, Whitman GJR, Wheeler GS, Horwitz LD, Weil JV (1993) Peripheral bypass-induced pulmonary and coronary vascular injury. Circulation 88:726–735

    PubMed  CAS  Google Scholar 

  26. Hattler BG, Zeevi A, Oddis CV, Finkel MS (1995) Cytokine induction during cardiac surgery: Analysis of TNF-alpha expression pre- and postcardiopulmonary bypass. J Card Surg 10 [4 Suppl]:418–422

    Article  PubMed  CAS  Google Scholar 

  27. Haeffner-Cavaillon N, Roussellier N, Ponzio O, Carreno MP, Laude M, Carpentier A, Kazatchkine MD (1989) Induction of interleukin-1 production in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 98:1100–1106

    PubMed  CAS  Google Scholar 

  28. Deng MC, Wiedner M, Erren M, Möllhoff T, Assmann G, Scheld HH (1995) Arterial and venous cytokine response to cardiopulmonary bypass for low risk CABG and relation to hemodynamics. Eur J Cardiothorac Surg 9:22–29

    Article  PubMed  CAS  Google Scholar 

  29. Markewitz A, Faist E, Lang S, Endres S, Hültner L, Reichart B (1993) Regulation of acute phase response after cardiopulmonary bypass by immunomodulation. Ann Thorac Surg 55:389–394

    Article  PubMed  CAS  Google Scholar 

  30. Markewitz A, Faist E, Lang S, Endres S, Fuchs D, Reichart B (1993) Successful restoration of cell-mediated immune response after cardiopulmonary bypass by immunomodulation. J Thorac Cardiovasc Surg 105:15–24

    PubMed  CAS  Google Scholar 

  31. Finn A, Naik S, Klein N, Levinsky R, Strobel S, Elliott M (1993) Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg 105:234–241

    PubMed  CAS  Google Scholar 

  32. Kunkel SL, Standiford T, Kasahara K, Strieter RM (1991) Interleukin-8 (IL-8): The major neutrophil chemotactic factor in the lung. Exp Lung Res 17:17–23

    Article  PubMed  CAS  Google Scholar 

  33. Hennein HA, Ebba H, Rodriguez JL, Merrick SH, Keith FM, Bronstein MH, Leung JM, Mangano DT, Greenfield LJ, Rankin JS (1994) Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 108:626–635

    PubMed  CAS  Google Scholar 

  34. Burns SA, Newburger JW, Xiao M, Mayer JE, Walsh AZ, Neufeld EJ (1995) Induction of interleukin-8 messenger RNA in heart and skeletal muscle during pediatric cardiopulmonary bypass. Circulation 92 [Suppl II]:315–321

    Google Scholar 

  35. Lee JD, Rhoades K, Economou JS (1995) Interleukin-4 inhibits the expression of tumor necrosis factors alpha and beta, interleukin-1 beta and -6 and interferon-gamma. Immunol Cell Biol 73:57–61

    Article  PubMed  CAS  Google Scholar 

  36. Standiford TJ, Strieter RM, Chensue SW, Westwick J, Kasahara K, Kunkel SL (1990) IL-4 inhibits the expression of IL-8 from stimulated human monocytes. J Immunol 145:1435–1439

    PubMed  CAS  Google Scholar 

  37. Daftarian PM, Kumar A, Kryworuchko M, Diaz-Mitoma F (1996) IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-alpha. J Immunol 157:12–20

    Google Scholar 

  38. Tabardel Y, Duchateau J, Schmartz D, Marecaux G, Shahla M, Barvais L, Leclerc JL, Vincent JL (1996) Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men. Surgery 119:76–80

    Article  Google Scholar 

  39. Seghaye M, Duchateau J, Bruniaux J, Demontoux S, Bosson C, Serraf A, Lecronier G, Mokhfi E, Planche C (1996) Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations. J Thorac Cardiovasc Surg 111:545–553

    Google Scholar 

  40. McBride WT, Armstrong MA, Crockard AD, McMurray TJ, Rea JM (1995) Cytokine balance and immunosuppressive changes at cardiac surgery: Contrasting response between patients and isolated CPB circuits. Br J Anaesth 75:724–733

    PubMed  CAS  Google Scholar 

  41. Berger S, Ballo H, Stutte HJ (1996) Immune complex-induced interleukin-6, interleukin-10 and prostaglandin secretion by human monocytes: A network of pro- and anti-inflammatory cytokines dependent on the antigen: antibody ratio. Eur J Immunol 26:1297–1301

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiothoracic Surgery, University Hospital, Josef Schneider-Str. 6, Germany

    M. Misoph & J. Babin-Ebell

Authors
  1. M. Misoph
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Babin-Ebell
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Misoph, M., Babin-Ebell, J. Interindividual variations in cytokine levels following cardiopulmonary bypass. Heart Vessels 12, 119–127 (1997). https://doi.org/10.1007/BF02767129

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02767129

Key words

Search

Navigation